California State Teachers Retirement System Cue Biopharma, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.77 - $3.09 $4,079 - $7,122	-2,305 Reduced 38.92%	3,618 $6,000
Q4 2023 Feb 13, 2024	SELL	$1.72 - $3.1 $2,929 - $5,279	-1,703 Reduced 22.33%	5,923 $15,000
Q3 2023 Nov 14, 2023	SELL	$2.23 - $4.69 $8,632 - $18,154	-3,871 Reduced 33.67%	7,626 $17,000
Q2 2023 Aug 21, 2023	BUY	$3.11 - $4.91 $35,755 - $56,450	11,497 New	11,497 $41,000
Q2 2022 Aug 15, 2022	SELL	$2.49 - $5.92 $94,478 - $224,622	-37,943 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.41 - $12.28 $11,593 - $32,284	-2,629 Reduced 6.48%	37,943 $185,000
Q4 2021 Feb 15, 2022	BUY	$10.86 - $17.85 $14,584 - $23,972	1,343 Added 3.42%	40,572 $459,000
Q3 2021 Nov 15, 2021	SELL	$10.06 - $15.3 $18,419 - $28,014	-1,831 Reduced 4.46%	39,229 $572,000
Q2 2021 Aug 16, 2021	SELL	$10.9 - $14.53 $35,435 - $47,237	-3,251 Reduced 7.34%	41,060 $478,000
Q4 2020 Feb 16, 2021	BUY	$11.12 - $16.4 $8,517 - $12,562	766 Added 1.76%	44,311 $554,000
Q3 2020 Nov 17, 2020	BUY	$15.05 - $23.54 $26,126 - $40,865	1,736 Added 4.15%	43,545 $655,000
Q2 2020 Aug 17, 2020	BUY	$12.7 - $30.73 $138,493 - $335,110	10,905 Added 35.29%	41,809 $1.03 Million
Q1 2020 May 13, 2020	BUY	$9.85 - $22.27 $3,496 - $7,905	355 Added 1.16%	30,904 $439,000
Q3 2019 Nov 15, 2019	BUY	$6.78 - $9.28 $16,095 - $22,030	2,374 Added 8.43%	30,549 $258,000
Q1 2019 May 09, 2019	BUY	$4.7 - $9.29 $5,273 - $10,423	1,122 Added 4.15%	28,175 $218,000
Q2 2018 Aug 14, 2018	BUY	$10.93 - $14.48 $147,336 - $195,190	13,480 Added 99.31%	27,053 $321,000
Q1 2018 May 15, 2018	BUY	$11.63 - $17.25 $157,853 - $234,134	13,573 New	13,573 $191,000

Others Institutions Holding CUE

# of Institutions

Shares Held

14.1M

Call Options Held

14.4K

Put Options Held

2.6K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account